AsOf

Recorded or changed on this day 2026-11-08

801–850 of 46,473 claims, by entity. Everything on 2026-11-08 →

superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · quarterly net income · 1,983,000,000 United States dollar
AbbVie quarterly net income: 1,983,000,000 United States dollar, claim clm_A3C668A4FA37 · ended · superseded by clm_A401A3579B68 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · quarterly operating income · 1,885,000,000 United States dollar
AbbVie quarterly operating income: 1,885,000,000 United States dollar, claim clm_A3F1416FDC9E · ended · superseded by clm_DCD9157C9133 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · quarterly net income · 2,747,000,000 United States dollar
AbbVie quarterly net income: 2,747,000,000 United States dollar, claim clm_A401A3579B68 · ended · superseded by clm_A19F5E6ED2F1 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · revenue · 17,444,000,000 United States dollar
AbbVie revenue: 17,444,000,000 United States dollar, claim clm_A43C77B35651 · ended · superseded by clm_7D34A43B5B1E · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · quarterly revenue · 8,619,000,000 United States dollar
AbbVie quarterly revenue: 8,619,000,000 United States dollar, claim clm_A47008E5C136 · ended · superseded by clm_1FA32CF37088 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · total equity · 14,708,000,000 United States dollar
AbbVie total equity: 14,708,000,000 United States dollar, claim clm_A4BBA0E13EE6 · ended · superseded by clm_30B4D4FDA112 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · cash and equivalents · 10,000,000 United States dollar
AbbVie cash and equivalents: 10,000,000 United States dollar, claim clm_A4E25B7E8BD9 · ended · superseded by clm_5C2DFBA489B1 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · shares outstanding · 1,590,066,459 shares
AbbVie shares outstanding: 1,590,066,459 shares, claim clm_A4E4164393FB · ended · superseded by clm_8AD2A24EAFA5 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · total equity · 13,274,000,000 United States dollar
AbbVie total equity: 13,274,000,000 United States dollar, claim clm_A6146EA9ECE9 · ended · superseded by clm_D0CAEDA52B47 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · quarterly net income · 2,783,000,000 United States dollar
AbbVie quarterly net income: 2,783,000,000 United States dollar, claim clm_A64BC7BE871E · ended · superseded by clm_A3C668A4FA37 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · cash and equivalents · 7,719,000,000 United States dollar
AbbVie cash and equivalents: 7,719,000,000 United States dollar, claim clm_A6644DA6B8CD · ended · superseded by clm_DCCC204D0954 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · shares outstanding · 1,767,384,632 shares
AbbVie shares outstanding: 1,767,384,632 shares, claim clm_A66CE3EA88E8 · ended · superseded by clm_F33386E6A71F · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · quarterly operating income · 4,306,000,000 United States dollar
AbbVie quarterly operating income: 4,306,000,000 United States dollar, claim clm_A6866F9C10EF · ended · superseded by clm_68DCF1A8E9E3 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · cash and equivalents · 7,257,000,000 United States dollar
AbbVie cash and equivalents: 7,257,000,000 United States dollar, claim clm_A6BEF465151C · ended · superseded by clm_42142B046C44 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · shares outstanding · 1,765,537,421 shares
AbbVie shares outstanding: 1,765,537,421 shares, claim clm_A6F2CE4E7D05 · ended · superseded by clm_89944DBAFE9E · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · quarterly operating income · 2,281,000,000 United States dollar
AbbVie quarterly operating income: 2,281,000,000 United States dollar, claim clm_A6F43E732D82 · ended · superseded by clm_854E200D3C92 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · quarterly revenue · 5,019,000,000 United States dollar
AbbVie quarterly revenue: 5,019,000,000 United States dollar, claim clm_A7029DF5DA96 · ended · superseded by clm_EEF0B5482085 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · total equity · 3,325,000,000 United States dollar
AbbVie total equity: 3,325,000,000 United States dollar, claim clm_A7EA278F1A95 · ended · superseded by clm_1A40CEC7F75A · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · cash and equivalents · 8,546,000,000 United States dollar
AbbVie cash and equivalents: 8,546,000,000 United States dollar, claim clm_A85CBBB42CDA · ended · superseded by clm_90B6D4FB71C7 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · operating income · 5,664,000,000 United States dollar
AbbVie operating income: 5,664,000,000 United States dollar, claim clm_A9B273E426B3 · ended · superseded by clm_5420B85B9EF4 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · shares outstanding · 1,766,558,253 shares
AbbVie shares outstanding: 1,766,558,253 shares, claim clm_AAA173651D55 · ended · superseded by clm_A66CE3EA88E8 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · quarterly net income · 2,308,000,000 United States dollar
AbbVie quarterly net income: 2,308,000,000 United States dollar, claim clm_AB85F916C6BF · ended · superseded by clm_712B18F8C713 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · quarterly operating income · 1,453,000,000 United States dollar
AbbVie quarterly operating income: 1,453,000,000 United States dollar, claim clm_ABFEE686F09F · ended · superseded by clm_852AC8B3FCCC · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · shares outstanding · 1,585,428,724 shares
AbbVie shares outstanding: 1,585,428,724 shares, claim clm_AC2DD135BFA3 · ended · superseded by clm_CF64F485A489 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · quarterly net income · 1,884,000,000 United States dollar
AbbVie quarterly net income: 1,884,000,000 United States dollar, claim clm_AEBAD82024FE · ended · superseded by clm_D228AC43E824 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · cash and equivalents · 7,906,000,000 United States dollar
AbbVie cash and equivalents: 7,906,000,000 United States dollar, claim clm_B187D122E493 · ended · superseded by clm_11F80DB2CE1F · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · total equity · 15,408,000,000 United States dollar
AbbVie total equity: 15,408,000,000 United States dollar, claim clm_B2E8F0E008D0 · ended · superseded by clm_55D207F88E40 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · quarterly net income · 3,179,000,000 United States dollar
AbbVie quarterly net income: 3,179,000,000 United States dollar, claim clm_B36E746D71D8 · ended · superseded by clm_0A98B6612119 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · quarterly operating income · 2,361,000,000 United States dollar
AbbVie quarterly operating income: 2,361,000,000 United States dollar, claim clm_B4012167F64D · ended · superseded by clm_7516913F42F9 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · total assets · 66,994,000,000 United States dollar
AbbVie total assets: 66,994,000,000 United States dollar, claim clm_B5248F34B0B8 · ended · superseded by clm_E218878A198F · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · quarterly revenue · 4,508,000,000 United States dollar
AbbVie quarterly revenue: 4,508,000,000 United States dollar, claim clm_B5C99B331875 · ended · superseded by clm_8FCC99AEFBF3 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · total equity · 3,553,000,000 United States dollar
AbbVie total equity: 3,553,000,000 United States dollar, claim clm_B65D7E4D5C6E · ended · superseded by clm_3A571D375C13 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · quarterly operating income · 2,387,000,000 United States dollar
AbbVie quarterly operating income: 2,387,000,000 United States dollar, claim clm_B8181F382DF3 · ended · superseded by clm_B4012167F64D · 1 source (1 primary) · conf 0.95
valid: Two independent sources agree, or a primary source states it: the record asserts this claim.
AbbVie · quarterly net income · 4,218,000,000 United States dollar
valid: Two independent sources agree, or a primary source states it: the record asserts this claim.
AbbVie · ticker · ABBV
AbbVie ticker: ABBV, claim clm_B87EDEAECF6B · valid · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · cash and equivalents · 10,648,000,000 United States dollar
AbbVie cash and equivalents: 10,648,000,000 United States dollar, claim clm_B886C897B1F0 · ended · superseded by clm_80A654D2EDD2 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · revenue · 25,638,000,000 United States dollar
AbbVie revenue: 25,638,000,000 United States dollar, claim clm_B8A18C367510 · ended · superseded by clm_9C790281A637 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · total equity · 13,550,000,000 United States dollar
AbbVie total equity: 13,550,000,000 United States dollar, claim clm_B8F0FB3F70F4 · ended · superseded by clm_B2E8F0E008D0 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · total equity · 13,076,000,000 United States dollar
AbbVie total equity: 13,076,000,000 United States dollar, claim clm_B93B782FADFB · ended · superseded by clm_875E4AB51928 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · cash and equivalents · 7,890,000,000 United States dollar
AbbVie cash and equivalents: 7,890,000,000 United States dollar, claim clm_B9988D4C4506 · ended · superseded by clm_386994D20FBA · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · total assets · 66,626,000,000 United States dollar
AbbVie total assets: 66,626,000,000 United States dollar, claim clm_B9C574866001 · ended · superseded by clm_94513531556F · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · quarterly operating income · 4,894,000,000 United States dollar
AbbVie quarterly operating income: 4,894,000,000 United States dollar, claim clm_BA8EDB44AFDD · ended · superseded by clm_8A7602897846 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · total equity · -183,000,000 United States dollar
AbbVie total equity: -183,000,000 United States dollar, claim clm_BAE788922C38 · ended · superseded by clm_E6BEEAB8A7CC · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · total assets · 133,960,000,000 United States dollar
AbbVie total assets: 133,960,000,000 United States dollar, claim clm_BAF68C4E73F9 · ended · superseded by clm_CD090548C18D · 1 source (1 primary) · conf 0.95
valid: Two independent sources agree, or a primary source states it: the record asserts this claim.
AbbVie · listed on · NYSE
AbbVie listed on: NYSE, claim clm_BBC331549951 · valid · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · shares outstanding · 1,764,833,246 shares
AbbVie shares outstanding: 1,764,833,246 shares, claim clm_BBC4CE8C1A41 · ended · superseded by clm_D979467F30C4 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · cash and equivalents · 6,017,000,000 United States dollar
AbbVie cash and equivalents: 6,017,000,000 United States dollar, claim clm_BBD4856469BA · ended · superseded by clm_B9988D4C4506 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · quarterly net income · 938,000,000 United States dollar
AbbVie quarterly net income: 938,000,000 United States dollar, claim clm_BC27B55DAB48 · ended · superseded by clm_48C26099DBC0 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · quarterly operating income · 1,596,000,000 United States dollar
AbbVie quarterly operating income: 1,596,000,000 United States dollar, claim clm_BC38E2A501A2 · ended · superseded by clm_69DD4A7597DD · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · quarterly revenue · 8,278,000,000 United States dollar
AbbVie quarterly revenue: 8,278,000,000 United States dollar, claim clm_BDC07E3C1093 · ended · superseded by clm_EF6AEA6051C0 · 1 source (1 primary) · conf 0.95

What the statuses mean